Clinical trials
Completed Observational Thrombosis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
204 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 2 |
| 2002 | 2 |
| 2003 | 3 |
| 2004 | 4 |
| 2005 | 5 |
| 2006 | 7 |
| 2007 | 7 |
| 2008 | 9 |
| 2009 | 6 |
| 2010 | 4 |
| 2011 | 9 |
| 2012 | 14 |
| 2013 | 8 |
| 2014 | 7 |
| 2015 | 6 |
| 2016 | 11 |
| 2017 | 9 |
| 2018 | 11 |
| 2019 | 14 |
| 2020 | 23 |
| 2021 | 8 |
| 2022 | 8 |
| 2023 | 9 |
| 2024 | 5 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 204 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| HemoSonics LLC | 18 |
| National Heart, Lung, and Blood Institute (NHLBI) | 6 |
| Bayer | 4 |
| Brigham and Women's Hospital | 4 |
| Boston Scientific Corporation | 3 |
| University Hospital, Bordeaux | 3 |
| University Hospital, Brest | 3 |
| University Hospital, Ghent | 3 |
| University of Aarhus | 3 |
| University of Edinburgh | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Thrombosis | 204 |
| Hemorrhage | 21 |
| Cardiovascular Diseases | 18 |
| Venous Thrombosis | 18 |
| Hemostatic Disorders | 16 |
| Venous Thromboembolism | 16 |
| Pulmonary Embolism | 15 |
| COVID-19 | 14 |
| Stroke | 12 |
| Thromboembolism | 12 |
Trials
Showing 1 to 25 of 204. Each trial links to its page on Pharma Observatory.
104 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.